Form 4: Disc Medicine Director Acquires 10,000 Stock Options
SEC Form 4 Filing
Director Donald William Nicholson acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.
Summary
- Donald William Nicholson, a director of Disc Medicine, Inc., acquired 10,000 stock options on June 12, 2024.
- The exercise price of these options is $38.85.
- The options vest upon the earlier of the company's 2025 annual meeting or the one-year anniversary of the grant date, contingent on continued service.
- Following the transaction, Nicholson beneficially owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting a standard stock option grant to a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company directors and officers.
Stakeholder Impact
- The acquisition of stock options by a director can align their interests with those of shareholders, potentially incentivizing them to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of stock option acquisition |
| 06/11/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.